Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the efficacy and safety of the drug NNC0487-0111 in adults with excess body weight and moderate-to-severe obstructive sleep apnoea OSA who are not treated with positive airway pressure. This Phase 3 study randomizes participants to receive either NNC0487-0111 or a placebo to assess their ability to lose weight and improve sleep apnoea symptoms. Participants will receive weekly injections under the skin using pre-filled pen-injectors of either NNC0487-0111 or placebo. Both groups will follow a reduced-calorie diet and increase physical activity. The treatment period lasts 80 weeks, during which the effects on body weight and sleep apnoea will be monitored. During the study, participants will have regular assessments including measurements of body weight, apnoea-hypopnoea index AHI, sleepiness scales, blood pressure, cholesterol levels, blood sugar, and other health indicators. Safety will be monitored through tracking adverse events up to 84 weeks. The study aims to measure changes from baseline to week 80 to evaluate treatment impact.
Actively Recruiting
Researchers are evaluating the efficacy and safety of a medicine called NNC0487-0111 in adults with overweight or obesity who also have moderate-to-severe obstructive sleep apnoea OSA treated with positive airway pressure. This Phase 3 study compares NNC0487-0111 to a placebo to see how well it helps reduce body weight and improve sleep apnoea symptoms over time. Participants will be randomly assigned to receive one of these treatments, which are injected under the skin weekly. Participants will receive either one of two dose levels of NNC0487-0111 or a matching placebo injection once a week. Both groups will also follow a reduced-calorie diet and increase physical activity as part of the study. The injections are given using pre-filled pen-injectors at areas such as the thigh, abdomen, or upper arm. The treatment period lasts up to 80 weeks, during which body weight and sleep apnoea severity are closely monitored. Throughout the study, participants will have regular assessments to measure changes in body weight, apnoea-hypopnoea index AHI, sleep quality, blood pressure, blood sugar, cholesterol, and other health markers. Safety is monitored by tracking adverse events until week 84. The study also evaluates improvements in sleep-related symptoms and the potential to reduce or stop positive airway pressure therapy. Total participation may last up to 84 weeks, including follow-up for safety and health outcomes.
Actively Recruiting
Parkinsons Disease PD is a movement disorder that affects balance, walking, and daily activities. This research aims to compare how well individuals with PD manage their own exercise plans independently using telerehabilitation versus following a supervised exercise program. The study focuses on improvements in quality of life, walking speed, physical function, and how well patients stick to their exercise routines. Participants will be randomly assigned to one of two groups for an 8-week program. One group will use a web-based system to perform exercises prescribed by a physical therapist at times they choose, twice a week. The other group will perform the same exercises twice a week via the web system but at scheduled times. Exercises include stretching, strengthening, balance, and neuromotor activities designed for home practice. During the study, participants cognitive and motor functions, balance, mobility, and quality of life will be assessed before and after the exercise program. They will keep an exercise diary and use a website to track their progress. Researchers will measure changes in motor impairment, exercise behavior, leg strength and endurance, walking speed, mobility, body position, and overall quality of life to understand the effects of managing exercise independently versus supervised sessions.
Actively Recruiting
Healthy Volunteer
This research aims to explore how smartphone addiction affects posture and breathing control among healthy university students aged 18 to 35 years. Excessive smartphone use has been linked to changes in head and thoracic posture and musculoskeletal complaints, which may impact breathing patterns. Understanding these relationships may help clarify the physical effects of smartphone overuse in young adults. Participants will undergo an observational assessment involving questionnaires for smartphone addiction using the Smartphone Addiction Scale-Short Form and breathing control using the Self Evaluation of Breathing Questionnaire. Posture will be evaluated with the New York Posture Rating Chart. Participants will be grouped based on addiction status according to scale cutoffs to compare postural and respiratory outcomes. During the study, participants will provide demographic information, including age, sex, smoking status, and smartphone usage duration. Researchers will analyze data to determine if smartphone addiction independently predicts postural problems and how it relates to breathing control. This cross-sectional study will be conducted between April and September 2026 and aims to provide evidence on the musculoskeletal and respiratory consequences of excessive smartphone use.